PR Campaigns Tied to Trade Publications Make Connection

The Israeli-based firm Peptor believed it had a hit on its hands with DiaPep277, an investigative drug that had shown in early testing to be potentially effective in halting
the progression of type I diabetes. Using this as a launching pad, Peptor executives hoped to raise the profile of their firm, and perhaps attract some investors among the major
global pharmaceutical companies.